Certara Inc (NAS:CERT)
$ 13.29 0.29 (2.23%) Market Cap: 2.14 Bil Enterprise Value: 2.22 Bil PE Ratio: 0 PB Ratio: 2.05 GF Score: 83/100

Certara Inc at Bank of America Securities 2021 Virtual Health Care Conference (Virtual) Transcript

May 11, 2021 / 06:45PM GMT
Release Date Price: $28.29 (-3.58%)
Dominique Schorn

Hi, everyone. It's Dominique Schorn, European Healthcare Specialist Sales at Bank of America Securities. Today, I'm pleased to have with me Certara, CFO; Andrew Schemick; and CEO, William Feehery .

I think just because it's a fireside chat, we'll kind of just go right into the questions, but maybe we start with a brief overview of Certara's biosimulation software and services business.

William F. Feehery
Certara, Inc. - CEO & Director

Yes. Thank you, Dominique. Very glad to be here with you today. And Certara is a biosimulation company. We started 20 years ago, developing software that allows us to simulate from a mechanistic standpoint what happens to a drug when it is injected or given to a human.

So we're modeling the transport absorption and metabolism combination of drug. We have a pretty unique software. It's used in quite a number of uses. And one of the interesting features of it is that we're modeling, not just what happens in 1 body, but we can run the software in what we call a virtual clinical trial, so we can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot